18F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
18F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts ; volume:17 ; number:1 ; day:11 ; month:10 ; year:2019 ; pages:1-15 ; date:12.2019
Journal of nanobiotechnology ; 17, Heft 1 (11.10.2019), 1-15, 12.2019
- Creator
-
Wang, Yanshu
Liu, Huanhuan
Yao, Defan
Li, Jinning
Yang, Shuyan
Zhang, Caiyuan
Chen, Weibo
Wang, Dengbin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12951-019-0534-7
- URN
-
urn:nbn:de:101:1-2020022307074129300020
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Yanshu
- Liu, Huanhuan
- Yao, Defan
- Li, Jinning
- Yang, Shuyan
- Zhang, Caiyuan
- Chen, Weibo
- Wang, Dengbin
- SpringerLink (Online service)
Other Objects (12)
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Change of Apoptosis and Glucose Metabolism in Lung Cancer Xenografts during Cytotoxic and Anti-Angiogenic Therapy Assessed by Annexin V Based Optical Imaging and 18F-FDG-PET/CT
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Change of Apoptosis and Glucose Metabolism in Lung Cancer Xenografts during Cytotoxic and Anti-Angiogenic Therapy Assessed by Annexin V Based Optical Imaging and 18F-FDG-PET/CT
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Change of Apoptosis and Glucose Metabolism in Lung Cancer Xenografts during Cytotoxic and Anti-Angiogenic Therapy Assessed by Annexin V Based Optical Imaging and 18F-FDG-PET/CT
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors